These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 17350

  • 1. Mechanisms of zymogen activation.
    Stroud RM, Kossiakoff AA, Chambers JL.
    Annu Rev Biophys Bioeng; 1977; 6():177-93. PubMed ID: 17350
    [No Abstract] [Full Text] [Related]

  • 2. Properties of the His57-Asp102 dyad of rat trypsin D189S in the zymogen, activated enzyme, and alpha1-proteinase inhibitor complexed forms.
    Kaslik G, Westler WM, Gráf L, Markley JL.
    Arch Biochem Biophys; 1999 Feb 15; 362(2):254-64. PubMed ID: 9989934
    [Abstract] [Full Text] [Related]

  • 3. A study of the active center of trypsinogen by comparative affinity chromatography of trypsinogen, alpha-, beta-, psi-trypsins, DIP-trypsin, chymotrypsinogen, alpha-chymotrypsin and elastase.
    Chauvet J, Acher R.
    Int J Pept Protein Res; 1974 Feb 15; 6(1):37-41. PubMed ID: 4850322
    [No Abstract] [Full Text] [Related]

  • 4. Probes of the mechanism of zymogen catalysis.
    Lonsdale-Eccles JD, Neurath H, Walsh KA.
    Biochemistry; 1978 Jul 11; 17(14):2805-9. PubMed ID: 687564
    [Abstract] [Full Text] [Related]

  • 5. Ala226 to Gly and Ser189 to Asp mutations convert rat chymotrypsin B to a trypsin-like protease.
    Jelinek B, Antal J, Venekei I, Gráf L.
    Protein Eng Des Sel; 2004 Feb 11; 17(2):127-31. PubMed ID: 15047908
    [Abstract] [Full Text] [Related]

  • 6. Sepharose-bound trypsin and activated sepharose-bound trypsinogen. Studies with small and large substrates.
    Knights RJ, Light A.
    Arch Biochem Biophys; 1974 Feb 11; 160(2):277-86. PubMed ID: 4831618
    [No Abstract] [Full Text] [Related]

  • 7. Zymogen activation: effect of peptides sequentially related to the bovine beta-trypsin N-terminus on Kazal inhibitor and benzamidine binding to bovine trypsinogen.
    Ascenzi P, Coletta M, Amiconi G, Bolognesi M, Guarneri M, Menegatti E.
    J Mol Recognit; 1988 Jun 11; 1(3):130-7. PubMed ID: 3273224
    [Abstract] [Full Text] [Related]

  • 8. Limited proteolyses in pancreatic chymotrypsinogens and trypsinogens.
    Rovery M.
    Biochimie; 1988 Sep 11; 70(9):1131-5. PubMed ID: 3147704
    [Abstract] [Full Text] [Related]

  • 9. Further studies on subunit III of bovine procarboxypeptidase A. Structure and reactivity of the weakly functional active site.
    Wicker C, Puigserver A.
    FEBS Lett; 1981 Jun 01; 128(1):13-6. PubMed ID: 7274452
    [No Abstract] [Full Text] [Related]

  • 10. Catalysis by chymotrypsinogen. Demonstration of an acyl-zymogen intermediate.
    Gertler A, Walsh KA, Neurath H.
    Biochemistry; 1974 Mar 12; 13(6):1302-10. PubMed ID: 4856029
    [No Abstract] [Full Text] [Related]

  • 11. [Effects of ethanol and acetaldehyde on proteolytic enzyme activity of the small intestine and pancreas].
    Skrzydlewska E.
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1974 Mar 12; 31-32():19-28. PubMed ID: 3152145
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of chronic ethanol ingestion on the pancreatic proteolytic enzymes and their inhibitors in the rat.
    Jalovaara P, Huttunen R.
    Scand J Gastroenterol; 1977 Mar 12; 12(7):785-92. PubMed ID: 563615
    [No Abstract] [Full Text] [Related]

  • 15. Catalysis by serine proteases and their zymogens. A study of acyl intermediates by circular dichroism.
    Kerr MA, Walsh KA, Neurath H.
    Biochemistry; 1975 Nov 18; 14(23):5088-94. PubMed ID: 1238107
    [Abstract] [Full Text] [Related]

  • 16. The isolation and partial characterization of trypsinogen, pancreatic secretory trypsin inhibitor and multiple forms of chymotrypsinogen and trypsin from the pancreas of the ostrich (Struthio camelus).
    Smith N, Naudé RJ, Oelofsen W, Lazure C, Patthy A.
    Int J Biochem; 1992 Jun 18; 24(6):877-85. PubMed ID: 1612178
    [Abstract] [Full Text] [Related]

  • 17. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
    Koepke J, Ermler U, Warkentin E, Wenzl G, Flecker P.
    J Mol Biol; 2000 May 05; 298(3):477-91. PubMed ID: 10772864
    [Abstract] [Full Text] [Related]

  • 18. Crystal structure reveals basis for the inhibitor resistance of human brain trypsin.
    Katona G, Berglund GI, Hajdu J, Gráf L, Szilágyi L.
    J Mol Biol; 2002 Feb 01; 315(5):1209-18. PubMed ID: 11827488
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The crystal and molecular structure of DIP-inhibited bovine trypsin at2.7Angstrom resolution.
    Stroud RM, Kay LM, Dickerson RE.
    Cold Spring Harb Symp Quant Biol; 1972 Feb 01; 36():125-40. PubMed ID: 4508129
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.